Meeting
2012 Gastrointestinal Cancers Symposium
Prevalence of risk factors among patients with hepatocellular carcinoma (HCC) and the general population in an employer group database.
Authors
QuynhChau Diem Doan
Abbott Laboratories, Kyle, TX
QuynhChau Diem Doan , Annette Beiderbeck , Qingshan Qian
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 190)
DOI
10.1200/jco.2012.30.4_suppl.190
Abstract #
190
Poster Bd #
A42
Abstract Disclosures
Similar Posters
First Author: Suzanne Graef
Poster
2023 ASCO Annual Meeting
The impact of high body mass index on hepatocellular carcinoma in viral hepatitis and cirrhosis.
First Author: Moonho Kim
Poster
2021 Gastrointestinal Cancers Symposium
Association between post-treatment (tx) alpha-fetoprotein (AFP) reduction and outcomes in real-world (rw) U.S. patients (pts) with advanced HCC (aHCC).
First Author: Xiaoliang Wang
Poster
2020 Gastrointestinal Cancers Symposium
Genomic characterization of HBV-infected hepatocellular carcinoma patients using circulating tumor DNA.
First Author: Daniel Lin